The Wistar Institute’s Alessandro Gardini, Ph.D., and lab have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular “bridge” complex demonstrate a new level of detail in the understanding of early neural development -; which is fundamental for the further understanding of neurodevelopmental syndromes.
What Does the Evidence Say About Immunotherapy Rechallenge in RCC?
Treatment of metastatic renal cell carcinoma (RCC) continues to rapidly evolve, with various combinations of immune checkpoint inhibitors (ICIs) and targeted tyrosine kinase inhibitors improving
June 22, 2023